Literature DB >> 11025170

Preliminary studies on the analgesic activity of latex of Calotropris procera.

S Dewan1, H Sangraula, V L Kumar.   

Abstract

In this study we have evaluated the analgesic activity of dry latex (DL) of Calotropis procera. A single oral dose of DL ranging from 165 to 830 mg/kg produced a significant dose dependent analgesic effect against acetic acid induced writhings. The effect of DL at a dose of 415 mg/kg was more pronounced as compared to a 100 mg/kg oral dose of aspirin. On the other hand DL (830 mg/kg) produced marginal analgesia in a tail-flick model which was comparable to aspirin. The analgesic effect of DL was delayed by 1 h by naloxone at a dose of 0. 5 mg/kg, i.p., which completely blocked the analgesic effect of morphine (10 mg/kg, i.p.). However, the effect of aspirin was not blocked by naloxone. The 830 mg/kg oral dose of DL did not produce toxic effects in mice and the LD(50) was found to be 3 g/kg.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11025170     DOI: 10.1016/s0378-8741(00)00272-5

Source DB:  PubMed          Journal:  J Ethnopharmacol        ISSN: 0378-8741            Impact factor:   4.360


  11 in total

1.  Cytotoxicity against tumor cell lines and anti-inflammatory properties of chitinases from Calotropis procera latex.

Authors:  Carolina Araújo Viana; Márcio V Ramos; José Delano Barreto Marinho Filho; Letícia Veras Costa Lotufo; Ingrid Samantha Tavares Figueiredo; Jefferson Soares de Oliveira; Pietro Mastroeni; José Vitor Lima-Filho; Nylane Maria Nunes Alencar
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2017-07-11       Impact factor: 3.000

2.  In vivo growth inhibition of sarcoma 180 by latex proteins from Calotropis procera.

Authors:  Jefferson S Oliveira; Letícia V Costa-Lotufo; Daniel P Bezerra; Nylane M N Alencar; José Delano B Marinho-Filho; Ingrid Samantha T Figueiredo; Manoel O Moraes; Claudia Pessoa; Ana Paula N N Alves; Márcio V Ramos
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2010-06-03       Impact factor: 3.000

3.  Calotropis procera latex-induced inflammatory hyperalgesia--effect of antiinflammatory drugs.

Authors:  Raman Sehgal; Vijay L Kumar
Journal:  Mediators Inflamm       Date:  2005-08-31       Impact factor: 4.711

4.  Antiinflammatory efficacy of extracts of latex of Calotropis procera against different mediators of inflammation.

Authors:  Soneera Arya; Vijay L Kumar
Journal:  Mediators Inflamm       Date:  2005-08-31       Impact factor: 4.711

5.  Calotropis procera -induced keratitis.

Authors:  Nidhi Pandey; A K Chandrakar; M L Garg; Santosh Singh Patel
Journal:  Indian J Ophthalmol       Date:  2009 Jan-Feb       Impact factor: 1.848

6.  Neuropharmacological Assessment of the Hydroethanolic Leaf Extract of Calotropis procera (Ait). R. Br. (Apocynaceae) in Mice.

Authors:  Ernest Obese; Elvis Ofori Ameyaw; Robert Peter Biney; Emmanuel Awintiig Adakudugu; Eric Woode
Journal:  Scientifica (Cairo)       Date:  2021-07-01

7.  Calotropis procera latex extract affords protection against inflammation and oxidative stress in Freund's complete adjuvant-induced monoarthritis in rats.

Authors:  Vijay L Kumar; Sanjeev Roy
Journal:  Mediators Inflamm       Date:  2007-03-19       Impact factor: 4.711

8.  Anti-inflammatory latex proteins of the medicinal plant Calotropis procera: a promising alternative for oral mucositis treatment.

Authors:  Márcio V Ramos; Ana Paula F Freitas; Renata F C Leitão; Deiziane V S Costa; Gilberto S Cerqueira; Nylane M N Alencar; Larissa Barbosa N Freitas; Gerly Anne C Brito; Dainesy S Martins; Conceição S Martins
Journal:  Inflamm Res       Date:  2020-06-02       Impact factor: 6.986

9.  Calotropis procera Root Extract Has the Capability to Combat Free Radical Mediated Damage.

Authors:  Shashank Kumar; Ashutosh Gupta; Abhay K Pandey
Journal:  ISRN Pharmacol       Date:  2013-10-09

10.  Antiedematogenic and antioxidant properties of high molecular weight protein sub-fraction of Calotropis procera latex in rat.

Authors:  Priyanka Chaudhary; Carolina de Araújo Viana; Marcio V Ramos; Vijay L Kumar
Journal:  J Basic Clin Pharm       Date:  2015-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.